Hydroxyacetone
Based on 1 Customer Validation
Hydroxyacetone is a toxic compound. Hydroxyacetone can be isolated from e-cigarette aerosols. Hydroxyacetone reduces the activity of cellular Mitochondrial reductase (with an IC50 of 5.53 mg/mL for mitochondrial reductase in BEAS-2B cells) and increases ROS levels. Hydroxyacetone induces mitochondrial stress and oxidative damage. Hydroxyacetone induces destabilization of F-actin. At high concentrations, Hydroxyacetone promotes cell rounding and Apoptotic body formation. Hydroxyacetone exerts toxic effects on cells including airway epithelial cells and possesses respiratory toxicity potential.\n
For research use only. We do not sell to patients.
- Purity: 98.93%
- CAS No.: 116-09-6
- Formula: C3H6O2
- Molecular Weight:74.08
-
Storage:
4°C, stored under nitrogen
* In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)
Biological Activity
|
Human Endogenous Metabolite |
Hydroxyacetone (0.01-10 mg/mL; 24 h) reduces mitochondrial reductase activity in BEAS-2B cells with an IC50 of 5.53 mg/mL and an IC70 of 2.49 mg/mL after 24 hours of exposure[1].
Hydroxyacetone (0.01-10 mg/mL; 24 h) increases mitochondrial membrane potential in BEAS-2B cells at 1 mg/mL and reduces it at 10 mg/mL after 24 hours of exposure[1].
Hydroxyacetone (0.01-10 mg/mL; 24 h) increases mitochondrial superoxide production in BEAS-2B cells at 1 mg/mL, with cell rounding and concentrated fluorescence observed at 10 mg/mL after 24 hours of exposure[1].
Hydroxyacetone (0.01-1 mg/mL; 24 h) significantly increases hydrogen peroxide release into the culture medium of BEAS-2B cells after 24 hours of incubation[1].
Hydroxyacetone (1-10 mg/mL; 2-8 h) induces concentration- and time-dependent F-actin destabilization in BEAS-2B cells, with cytoplasmic and perinuclear filaments more sensitive than cortical actin, and complete loss of filamentous actin with cell rounding and blebbing at 10 mg/mL after 8 hours of exposure[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:BEAS-2B human bronchial epithelial cells
-
Concentration:0.01-10 mg/mL
-
Incubation Time:24 h
-
Result:Showed concentration-dependent reduction in mitochondrial reductase activity.
Determined IC50 (concentration reducing activity by 50%) as 5.53 mg/mL, and IC70 (concentration reducing activity by 70%) as 2.49 mg/mL.
Observed a significant reduction in activity at 10 mg/mL.
Chemical Information
-
CAS No. 116-09-6
-
Appearance Liquid (Density: 1.082 g/cm3)
-
Molecular Weight 74.08
-
Formula C3H6O2
-
Color Colorless to light yellow
-
SMILES
CC(CO)=O
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
4°C, stored under nitrogen
* In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)
Solvent & Solubility
DMSO : 100 mg/mL (1349.89 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (stored under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (stored under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (33.75 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (33.75 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL. * In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation
-
Data Sheet (272 KB)
-
SDS (466 KB)
- English - EN (466 KB)
- Français - FR (466 KB)
- Deutsch - DE (466 KB)
- Norwegian - NO (466 KB)
- Español - ES (466 KB)
- Swedish - SV (466 KB)
- Italian - IT (466 KB)
- Korean - KR (466 KB)
- Portuguese - PT (466 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (stored under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 13.4989 mL | 67.4946 mL | 134.9892 mL | 337.4730 mL |
| 5 mM | 2.6998 mL | 13.4989 mL | 26.9978 mL | 67.4946 mL | |
| 10 mM | 1.3499 mL | 6.7495 mL | 13.4989 mL | 33.7473 mL | |
| 15 mM | 0.8999 mL | 4.4996 mL | 8.9993 mL | 22.4982 mL | |
| 20 mM | 0.6749 mL | 3.3747 mL | 6.7495 mL | 16.8736 mL | |
| 25 mM | 0.5400 mL | 2.6998 mL | 5.3996 mL | 13.4989 mL | |
| 30 mM | 0.4500 mL | 2.2498 mL | 4.4996 mL | 11.2491 mL | |
| 40 mM | 0.3375 mL | 1.6874 mL | 3.3747 mL | 8.4368 mL | |
| 50 mM | 0.2700 mL | 1.3499 mL | 2.6998 mL | 6.7495 mL | |
| 60 mM | 0.2250 mL | 1.1249 mL | 2.2498 mL | 5.6245 mL | |
| 80 mM | 0.1687 mL | 0.8437 mL | 1.6874 mL | 4.2184 mL | |
| 100 mM | 0.1350 mL | 0.6749 mL | 1.3499 mL | 3.3747 mL |
- Hydroxyacetone
- 116-09-6
- Mitochondrial Metabolism
- Reactive Oxygen Species (ROS)
- Arp2/3 Complex
- Apoptosis
- human airway epithelial cells
- 3D human EpiAirway tissues
- F-actin
- hydrogen peroxide
- reactive oxygen species
- mitochondrial respiratory chain Complex IV
- mitochondrial stress
- actin filaments
- oxidative stress
- BEAS-2B cells
- Inhibitor
- inhibitor
- inhibit